Published • loading... • Updated
RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit
The complaint says Regencell hid market-manipulation risks that exposed investors to significant financial loss and possible regulatory scrutiny.
- Bronstein, Gewirtz & Grossman, LLC announced a class action lawsuit against Regencell Bioscience Holdings Ltd. yesterday, alleging federal securities law violations.
- The Complaint alleges that during the Class Period between October 28, 2024, and October 31, 2025, the Company made materially false and misleading statements regarding its business operations and compliance policies.
- Specifically, Defendants allegedly failed to disclose that Regencell was vulnerable to market manipulation, exposing Regencell Investors to significant financial risk and heightened regulatory scrutiny.
- Regencell Investors who suffered losses have until June 23, 2026, to request that the Court appoint them as lead plaintiff in this Regencell Securities Class Action.
- "Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Founding Partner Peretz Bronstein. Contact Nathan Miller at 917-590-0911.
Insights by Ground AI
23 Articles
23 Articles
Globe NewswireReposted by 
Carroll County Mirror-Democrat
Carroll County Mirror-DemocratBronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Regencell (RGC) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 6/23/2026...
Coverage Details
Total News Sources23
Leaning Left4Leaning Right2Center7Last UpdatedBias Distribution54% Center
Bias Distribution
- 54% of the sources are Center
54% Center
L 31%
C 54%
15%
Factuality
To view factuality data please Upgrade to Premium
